Gating strategy used to identify T cell subsets and differentiation stages (PPTX 227 kb
Timeline of MCC-002 treatment. A 63-year-old woman (MCC-002) was diagnosed with invasive ductal brea...
Additional file 1: Supplementary Figure 1. The composition of T cell subsets at different age groups...
Tissue microarray (TMA) analysis of recurrence-free survival and overall survival curves related to ...
Clinico-pathological characteristics of younger and older patients. (DOCX 15Â kb
Kaplan-Meier analysis of clinico-pathological parameters in older patients. (DOCX 17Â kb
Table S1. Gene membership of the immune cell type metagenes and the immune function metagenes. (XLSX...
Figure S2. Age of patient and MKI67 expression in cases with pathologic complete response (pCR) and ...
The independent association between age at diagnosis and gene expression signatures (>10,000) in a l...
Table S1. Comparison of clinical characteristics of study patients and remaining N9831 cohort. (DOCX...
Flow cytometry gating strategy. Representative flow cytometry plots showing the gating strategy used...
Table S2. Patient and tumor characteristics. Demographic data for patients and clinical measurements...
Figure S1. Flowcytometric gating of cell subsets. Gating strategies for the DC subsets as well as Tr...
Table S1. Phenotype of immune cell subsets. An overview of the used phenotypic definitions for each ...
Memory phenotyping of CD4+ and CD8+ T cells during NC in HER2-negative and HER2-positive patients. C...
Characteristics of control subjects by age and race in the Carolina Breast Cancer Study phases I and...
Timeline of MCC-002 treatment. A 63-year-old woman (MCC-002) was diagnosed with invasive ductal brea...
Additional file 1: Supplementary Figure 1. The composition of T cell subsets at different age groups...
Tissue microarray (TMA) analysis of recurrence-free survival and overall survival curves related to ...
Clinico-pathological characteristics of younger and older patients. (DOCX 15Â kb
Kaplan-Meier analysis of clinico-pathological parameters in older patients. (DOCX 17Â kb
Table S1. Gene membership of the immune cell type metagenes and the immune function metagenes. (XLSX...
Figure S2. Age of patient and MKI67 expression in cases with pathologic complete response (pCR) and ...
The independent association between age at diagnosis and gene expression signatures (>10,000) in a l...
Table S1. Comparison of clinical characteristics of study patients and remaining N9831 cohort. (DOCX...
Flow cytometry gating strategy. Representative flow cytometry plots showing the gating strategy used...
Table S2. Patient and tumor characteristics. Demographic data for patients and clinical measurements...
Figure S1. Flowcytometric gating of cell subsets. Gating strategies for the DC subsets as well as Tr...
Table S1. Phenotype of immune cell subsets. An overview of the used phenotypic definitions for each ...
Memory phenotyping of CD4+ and CD8+ T cells during NC in HER2-negative and HER2-positive patients. C...
Characteristics of control subjects by age and race in the Carolina Breast Cancer Study phases I and...
Timeline of MCC-002 treatment. A 63-year-old woman (MCC-002) was diagnosed with invasive ductal brea...
Additional file 1: Supplementary Figure 1. The composition of T cell subsets at different age groups...
Tissue microarray (TMA) analysis of recurrence-free survival and overall survival curves related to ...
DOI
Add to ORKG